Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

for
Cancer, Cancer Risk
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: All

Age: 18+

Code: NCT03977402

Recruiting

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

for
Solid Tumor
Location: Columbus OH, West Valley City UT
Sponsor: Jabez Bioscience, Inc

Sex: All

Age: 18+

Code: NCT06801002

Phase 1, Recruiting

Impact of the Coronavirus (COVID-19) on Patients With Cancer

for
Cancer, COVID-19
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70+

Code: NCT04330521

Recruiting

SNV1521 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Philadelphia PA, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06220864

Phase 1, Recruiting

Patient-Derived Xenografts to Reduce Cancer Health Disparities

for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21 - 70+

Code: NCT04410302

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Psilocybin Therapy in Advanced Cancer

for
Advanced Cancer
Location: New York NY, Aurora CO
Sponsor: NYU Langone Health

Sex: All

Age: 21 - 70+

Code: NCT05398484

Phase 2, Phase 3, Recruiting

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

for
Pediatric Cancer
Location: Wilmington DE
Sponsor: Nemours Children's Clinic

Sex: All

Age: 0+

Code: NCT05294302

Recruiting

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

for
Cancer, Metabolic Disease, Aneurysm, Neurologic Disorder
Location: Watertown MA
Sponsor: Hercules

Sex: All

Age: 18+

Code: NCT06212479

Recruiting

Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT03310879

Phase 2, Recruiting

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for
Cancer
Location: Milford DE, Paoli PA, Dover DE, Elk Grove Village IL,
Sponsor: N-Power Medicine

Sex: All

Age: 18 - 70+

Code: NCT06877884

Recruiting

IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)

for
Depression, Depressive Symptoms, Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06582784

Recruiting

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

for
DIGEST, Evidence Based Measurement, Dysphagia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07283653

Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for
Solid Tumors, Hematologic Malignancies
Location: New York NY, Ann Arbor MI, Nashville TN, Omaha NE,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07195916

Phase 1, Recruiting

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

for
Advanced Solid Tumor, NSCLC
Location: Lafayette IN, San Antonio TX, Spokane WA
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05417321

Phase 1, Phase 2, Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

for
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT04897321

Phase 1, Recruiting

Resilience Mobile App for Teens and Young Adults With Cancer

for
Cancer
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 12 - 25

Code: NCT05842902

Recruiting

Genetic Information Assistant in Telegenetics

for
Gene Mutation-Related Cancer, Genetic Predisposition
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: All

Age: 18+

Code: NCT06089421

Recruiting

A Study of LM-24C5 For Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Ocala FL
Sponsor: LaNova Medicines Limited

Sex: All

Age: 18+

Code: NCT06187402

Phase 1, Phase 2, Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: New York NY, Baltimore MD, Washington D.C. DC, Miami FL,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05663502

Recruiting

Personalized Oncogenomics (POG) Program of British Columbia

for
Metastatic Cancers, Advanced Cancers,
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18 - 70+

Code: NCT02155621

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial